Oxygen delivery enhancers: Past, present, and future

被引:13
|
作者
Borrione, P. [1 ,2 ]
Mastrone, A. [2 ]
Salvo, R. A. [2 ]
Spaccamiglio, A. [2 ]
Grasso, L. [2 ]
Angeli, A. [1 ]
机构
[1] Univ Turin, Div Internal Med, Turin, Italy
[2] Consorzio Reg Antidoping, Turin, Italy
关键词
D O I
10.1007/BF03345588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In endurance sport the delivery of oxygen to muscles plays a critical role. Indeed, muscle performance declines during prolonged and intense activity as a consequence of the shift from the aerobic to the anaerobic metabolism with an increase of lactate. To enhance the aerobic capacity 2 alternatives may be used: increasing either the transport or the delivery of oxygen. In this setting, blood doping is the practice of illicitly using a drug or blood product to improve athletic performance. Based on this definition, blood doping techniques may include: 1) blood transfusion (autologous or omologous); 2) erythropoiesis-stimulating substances [recombinant human erythropoietin (alpha, beta, omega), darbepoietin-alpha, continuous erythropoiesis receptor activator, hematidel; 3) blood substitutes (hemoglobin-based oxygen carriers, perfluorocarbon emulsions); 4) allosteric modulators of hemoglobin (RSR-13 and RSR-4); 5) gene doping (human erythropoietin gene transfection); 6) gene regulation (hypoxia-inducible transcription factors pathway). In the present overview we will briefly describe the above-mentioned techniques with the aim of underlining potential hematological alternatives to gene doping for increasing aerobic capacity in sport.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 50 条
  • [1] Oxygen delivery enhancers: Past, present, and future
    P. Borrione
    A. Mastrone
    R. A. Salvo
    A. Spaccamiglio
    L. Grasso
    A. Angeli
    [J]. Journal of Endocrinological Investigation, 2008, 31 : 185 - 192
  • [2] Inspired oxygen: present, past, and future
    West, John B.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2021, 321 (06) : L1131 - L1133
  • [3] Antigen Delivery Systems: Past, Present, and Future
    Ko, Hyun-Jeong
    Kim, Yeon-Jeong
    [J]. BIOMOLECULES & THERAPEUTICS, 2023, 31 (04) : 370 - 387
  • [4] Biomaterials and Drug Delivery: Past, Present, and Future
    Kopecek, Jindrich
    [J]. MOLECULAR PHARMACEUTICS, 2010, 7 (04) : 922 - 925
  • [5] Insulin delivery methods: Past, present and future
    Shah, Rima B.
    Patel, Manhar
    Maahs, David M.
    Shah, Viral N.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2016, 6 (01) : 1 - 9
  • [6] Nanoparticles in drug delivery: Past, present and future
    Couvreur, P.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 21 - 23
  • [7] Online Video Delivery: Past, Present, and Future
    Hua, Kien A.
    [J]. ACM TRANSACTIONS ON MULTIMEDIA COMPUTING COMMUNICATIONS AND APPLICATIONS, 2013, 9 (01)
  • [8] Drug delivery systems: Past, present, and future
    Mainardes, RM
    Silva, LP
    [J]. CURRENT DRUG TARGETS, 2004, 5 (05) : 449 - 455
  • [9] Delivery room resuscitation past, present, and the future
    Perlman, JM
    Kattwinkel, J
    [J]. CLINICS IN PERINATOLOGY, 2006, 33 (01) : 1 - +
  • [10] Inhaled drug delivery: Past, present, and future
    Yue, Ludan
    Zhang, Xueyang
    Zhao, Chenchen
    Chen, Rongchang
    Chen, Xiaoyuan
    Rao, Lang
    [J]. NANO TODAY, 2023, 52